Clive R. Seed

3.6k total citations
96 papers, 2.0k citations indexed

About

Clive R. Seed is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Clive R. Seed has authored 96 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 43 papers in Infectious Diseases and 34 papers in Hepatology. Recurrent topics in Clive R. Seed's work include Blood donation and transfusion practices (28 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (26 papers). Clive R. Seed is often cited by papers focused on Blood donation and transfusion practices (28 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (26 papers). Clive R. Seed collaborates with scholars based in Australia, United States and United Kingdom. Clive R. Seed's co-authors include A. J. Keller, Philip Kiely, T.J. Cobain, E. A. C. Follett, Tom Krusius, P.L. Yap, F. McOmish, Elina Kolho, B. C. Dow and R. Naukkarinen and has published in prestigious journals such as Journal of Clinical Microbiology, Emerging infectious diseases and American Journal of Transplantation.

In The Last Decade

Clive R. Seed

90 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clive R. Seed Australia 25 1.1k 950 627 516 472 96 2.0k
Sally Caglioti United States 16 826 0.7× 552 0.6× 710 1.1× 283 0.5× 580 1.2× 18 1.6k
Alan D. Kitchen United Kingdom 20 674 0.6× 815 0.9× 397 0.6× 182 0.4× 457 1.0× 45 1.7k
David E. Krysztof United States 20 709 0.6× 395 0.4× 906 1.4× 274 0.5× 846 1.8× 35 1.8k
Shimian Zou United States 27 930 0.8× 602 0.6× 477 0.8× 696 1.3× 527 1.1× 50 2.1k
Gregory A. Foster United States 22 805 0.7× 480 0.5× 1.4k 2.3× 237 0.5× 1.4k 3.0× 46 2.6k
Josiane Pillonel France 29 1.3k 1.1× 650 0.7× 1.0k 1.7× 411 0.8× 231 0.5× 112 2.2k
Margaret Fearon Canada 25 898 0.8× 242 0.3× 849 1.4× 123 0.2× 501 1.1× 54 1.7k
Philip Kiely Australia 18 602 0.5× 401 0.4× 347 0.6× 191 0.4× 94 0.2× 46 972
Katy Davison United Kingdom 19 574 0.5× 251 0.3× 271 0.4× 368 0.7× 170 0.4× 54 1.3k
Jean Pierre Allain United Kingdom 17 483 0.4× 236 0.2× 474 0.8× 159 0.3× 75 0.2× 30 1.3k

Countries citing papers authored by Clive R. Seed

Since Specialization
Citations

This map shows the geographic impact of Clive R. Seed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive R. Seed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive R. Seed more than expected).

Fields of papers citing papers by Clive R. Seed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive R. Seed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive R. Seed. The network helps show where Clive R. Seed may publish in the future.

Co-authorship network of co-authors of Clive R. Seed

This figure shows the co-authorship network connecting the top 25 collaborators of Clive R. Seed. A scholar is included among the top collaborators of Clive R. Seed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clive R. Seed. Clive R. Seed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoad, Veronica C., Clive R. Seed, Philip Kiely, et al.. (2023). Removal of UK‐donor deferral for variant Creutzfeldt–Jakob disease: A large donation gain in Australia. Vox Sanguinis. 118(10). 891–894. 2 indexed citations
2.
Hoad, Veronica C., et al.. (2023). Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations. Vox Sanguinis. 118(6). 480–487. 2 indexed citations
3.
Cheng, Qinglu, Veronica C. Hoad, Clive R. Seed, et al.. (2023). Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis. Vox Sanguinis. 118(6). 471–479. 3 indexed citations
4.
Kiely, Philip, Veronica C. Hoad, Clive R. Seed, & Iain B. Gosbell. (2022). Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review. Transfusion Medicine and Hemotherapy. 49(4). 218–229. 3 indexed citations
5.
Lewin, Antoine, Sheila F. O’Brien, Yves Grégoire, et al.. (2021). HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men. Vox Sanguinis. 117(2). 201–207. 6 indexed citations
6.
Saeed, Sahar, Antoine Lewin, Helen M. Faddy, et al.. (2021). Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review. medRxiv. 117(4). 476–487. 4 indexed citations
7.
Saeed, Sahar, Antoine Lewin, Helen M. Faddy, et al.. (2021). Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review. Vox Sanguinis. 117(4). 476–487. 6 indexed citations
8.
9.
10.
Gosbell, Iain B., et al.. (2019). Undetectable does not equal untransmittable for HIV and blood transfusion. Vox Sanguinis. 114(6). 628–630. 13 indexed citations
11.
Davison, Katy, Yves Grégoire, Marc Germain, et al.. (2019). Changing the deferral for men who have sex with men – an improved model to estimate HIV residual risk. Vox Sanguinis. 114(7). 666–674. 15 indexed citations
12.
O’Brien, Sheila F., Yves Grégoire, Josiane Pillonel, et al.. (2019). HIV residual risk in Canada under a three‐month deferral for men who have sex with men. Vox Sanguinis. 115(2). 133–139. 23 indexed citations
13.
14.
15.
Hoad, Veronica C., et al.. (2018). Modelling the risk of transfusion‐transmitted syphilis: a reconsideration of blood donation testing strategies. Vox Sanguinis. 114(2). 107–116. 14 indexed citations
16.
Hoad, Veronica C., et al.. (2018). Estimation of human T‐lymphotropic virus incidence in blood donors from observed prevalence. Vox Sanguinis. 113(8). 814–815. 6 indexed citations
17.
Shrestha, Ashish C., Robert L. Flower, Clive R. Seed, et al.. (2017). Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply.. PubMed. 15(3). 191–198. 4 indexed citations
18.
Seed, Clive R., et al.. (2017). Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia. Vox Sanguinis. 112(8). 723–732. 18 indexed citations
19.
O’Brien, Sheila F., Gilles Delage, Clive R. Seed, et al.. (2015). The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries. Transfusion Medicine Reviews. 29(3). 162–171. 44 indexed citations
20.
Seed, Clive R., Philip Kiely, & A. J. Keller. (2005). Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Internal Medicine Journal. 35(10). 592–598. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally Caglioti Breakdown of academic impact, for papers by Alan D. Kitchen Breakdown of academic impact, for papers by David E. Krysztof Breakdown of academic impact, for papers by Shimian Zou Breakdown of academic impact, for papers by Gregory A. Foster Breakdown of academic impact, for papers by Josiane Pillonel Breakdown of academic impact, for papers by Margaret Fearon Breakdown of academic impact, for papers by Philip Kiely Breakdown of academic impact, for papers by Katy Davison Breakdown of academic impact, for papers by Jean Pierre Allain
Rankless by CCL
2026